Piramal Pharma Solutions has introduced tablet-in-capsule (TiC) technology, a novel drug delivery platform designed to enhance patient compliance and optimize formulation flexibility. This innovation allows multiple tablets to be encapsulated within a single dosage form, offering advantages in combination therapies, clinical trials, and complex drug development.
Piramal Pharma Solutions (PPS), the contract development and manufacturing arm of Piramal Pharma Ltd, has announced the launch of its tablet-in-capsule (TiC) capabilities, marking a significant advancement in pharmaceutical drug delivery systems.
The TiC technology enables the encapsulation of one or more tablets within a single capsule shell, providing unique benefits for combination therapies, clinical trial supplies, and customized formulations. This approach simplifies dosing regimens, improves patient adherence, and allows pharmaceutical companies greater flexibility in drug development.
Industry experts highlight that TiC technology is particularly valuable for oncology, rare diseases, and complex therapeutic areas, where multiple active ingredients often need to be delivered simultaneously. PPS’s innovation aligns with its broader strategy of offering end-to-end solutions across drug development and manufacturing, reinforcing its position as a global leader in contract pharma services.
Key Highlights
-
New Capability: Launch of tablet-in-capsule (TiC) technology by Piramal Pharma Solutions.
-
Patient Benefits: Simplifies dosing, improves compliance, and enhances convenience.
-
Pharma Applications: Supports combination therapies, clinical trials, and complex drug formulations.
-
Strategic Impact: Strengthens PPS’s global CDMO (Contract Development and Manufacturing Organization) portfolio.
-
Market Relevance: Valuable for oncology, rare diseases, and multi-drug regimens.
-
Innovation Focus: Aligns with PPS’s mission to deliver advanced, patient-centric drug delivery solutions.
Sources: Economic Times – Piramal Pharma Solutions Innovation Update; Business Standard – Pharma Technology Developments; Moneycontrol – Contract Pharma Industry News